MORGAN STANLEY - 31 Dec 2024 SCHEDULE 13G Report for Sage Therapeutics, Inc. Common Stock (SAGE)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Sage Therapeutics, Inc. Common Stock
Symbol
SAGE
Shares outstanding
61,391,784 shares
Disclosed Ownership
4,542,992 shares
Ownership
7.4%
Form type
SCHEDULE 13G
Filing time
05 Feb 2025, 10:41:34 UTC
Date of event
31 Dec 2024
Next filing
06 Mar 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 7.4% 4,542,992 0 4,439,775 Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley & Co. LLC 5.5% 3,394,815 0 3,394,815 Christopher O'Hara Authorized Signatory, Morgan Stanley & Co. LLC